公司資料

Veradigm 股價、新聞與催化劑

股票代碼:: MDRX
交易所:: NASDAQ
產業:: Biopharma
所在地:: United States

股票表現

5.00 USD (-2.72%)

收盤價

最後更新: 2026年10月1日

—

市值

股價為何變動

截至 2026年10月1日，MDRX 下跌 2.72%，收於 $5.00。目前新聞監測窗口內未發現新的同公司新聞。

公司概覽

業務概覽

Veradigm is a healthcare information and analytics company focused on software, data, and workflow tools for providers and life-sciences customers. Its business is more about information infrastructure than therapeutic innovation.

所在地與產業分類

Headquartered in the United States and listed on NASDAQ, Veradigm sits in healthcare IT.

商業模式特徵

Revenue depends on software subscriptions, data products, and the commercialization of workflow tools across healthcare users.

生技產業定位

Veradigm is outside biotech and belongs to the healthcare information layer, where software adoption and execution matter most.

未來催化劑

Veradigm's catalysts are claims-data products, payer and life-science software demand, and any operating update that clarifies the turnaround path. The company is still a software-and-data execution story.